Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06177795 · ClinicalTrials.gov registry record · NA
Increasing Screening for Cancer Using EHR-Nudges
A NA study of Breast Cancer, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 21,120
- Enrollment target
- 2
- Study locations
NCT06177795: Completed NA study of Breast Cancer, sponsored by Abramson Cancer Center at Penn Medicine.
NCT06177795 is a NA study of Breast Cancer that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 21,120 participants, above the 2,786-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (658% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06177795, a NA study of Breast Cancer, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 21,120 participants
- Enrollment target
- 2
- Study locations
Study Summary
In this study, personalized nudges to clinicians and patients will be evaluated to help increase breast cancer screening rates in accordance with USPSTF guidelines among women with a primary care visit, with a particular emphasis on those at high risk for non-completion of cancer screening. In partnership with Penn Medicine (Penn) and Case Western Reserve University-University Hospitals (UH), two complementary, concurrent, 6-month, cluster-randomized, pragmatic trials will be conducted. Those assigned to the intervention arm will receive the following clinician and patient level nudge interventions: clinicians will receive a default pended order for a mammogram in the visit encounter in the EHR (Penn and UH), and patients will receive post-visit text message reminders to encourage them to schedule their mammogram (Penn). Patients identified as high risk for noncompletion will be individually randomized to receive an additional bidirectional text message nudge or the standard text messaging (Penn).
Primary Outcome
The primary outcome is screening mammogram completion within 3 months after the first eligible primary care visit.
Conditions Studied
Interventions
- BEHAVIORAL Default pended order
- BEHAVIORAL Post-visit patient text messaging
- BEHAVIORAL High risk bidirectional post-visit text messaging
Study Locations (2)
Ohio
- Case Western Reserve University/University Hospitals - Cleveland
Pennsylvania
- University of Pennsylvania Health System - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,120 participants |
| Start Date | 2023-12-18 |
| Est. Completion | 2025-04-07 |
| Phase | NA |
What the finished NCT06177795 record still lists
NCT06177795 is an interventional study that assigns participants to a tested intervention. Its 21,120 participants enrollment target places it among the larger protocols in the corpus, above the 2,786-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (658% higher).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Default pended order is the first listed.
NCT06177795 reports a single indexed study location in Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06177795 about?
NCT06177795 is a clinical study titled "Increasing Screening for Cancer Using EHR-Nudges". In this study, personalized nudges to clinicians and patients will be evaluated to help increase breast cancer screening rates in accordance with USPSTF guidelines among women with a primary care visit, with a particular emphasis on those at high risk for non-completion of cancer screening. In partn...
What is the current status of trial NCT06177795?
This trial is currently completed. It is a NA study. The enrollment target is 21,120 participants. The study started on 2023-12-18. Estimated completion is 2025-04-07.
What conditions does trial NCT06177795 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT06177795?
The interventions under investigation include: Default pended order (BEHAVIORAL), Post-visit patient text messaging (BEHAVIORAL), High risk bidirectional post-visit text messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT06177795?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06177795 being conducted?
This trial has 2 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06177795's enrollment target sits among peer trials
21,120 9th of 1224 higher than 1,216 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07213531 · 21,000 participants
Enhanced Valves Interventions and Safe AI Generated End Results
- NCT06047041 · 21,350 participants · NA
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
- NCT06062342 · 20,400 participants · NA
Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
- NCT05832307 · 22,000 participants · NA
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI